Liquid biopsy for the diagnosis of HPV-associated head and neck cancer.
作者信息
Faden Daniel L
机构信息
Department of Otolaryngology-Head and Neck Surgery, Mass Eye and Ear, Boston, Massachusetts.
Massachusetts General Hospital, Boston, Massachusetts.
出版信息
Cancer Cytopathol. 2022 Jan;130(1):12-15. doi: 10.1002/cncy.22497. Epub 2021 Aug 10.
Abstract
摘要
相似文献
1
Liquid biopsy for the diagnosis of HPV-associated head and neck cancer.
Cancer Cytopathol. 2022 Jan;130(1):12-15. doi: 10.1002/cncy.22497. Epub 2021 Aug 10.
2
The use of plasma circulating tumor DNA for early detection of oligometastatic disease in HPV positive oropharyngeal squamous cell carcinoma.
Oral Oncol. 2023 Apr;139:106357. doi: 10.1016/j.oraloncology.2023.106357. Epub 2023 Mar 9.
3
Circulating tumor DNA in head and neck cancer: Early successes and future promise.
Cancer. 2022 Jun 1;128(11):2061-2063. doi: 10.1002/cncr.34189. Epub 2022 Mar 17.
4
Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Oral Oncol. 2023 Dec;147:106584. doi: 10.1016/j.oraloncology.2023.106584. Epub 2023 Oct 12.
5
Emerging role of blood-based biomarker testing in HPV-mediated head and neck squamous cell carcinoma.
Cancer Cytopathol. 2024 Jan;132(1):7-9. doi: 10.1002/cncy.22735. Epub 2023 Jun 23.
6
Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
Head Neck. 2022 Aug;44(8):E25-E30. doi: 10.1002/hed.27081. Epub 2022 May 12.
7
Characterization of high risk human papilloma virus genotypes associated with oropharyngeal cancers in a Nigerian population.
Pan Afr Med J. 2021 Jan 15;38:40. doi: 10.11604/pamj.2021.38.40.27309. eCollection 2021.
8
HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Semin Diagn Pathol. 2015 Sep;32(5):344-51. doi: 10.1053/j.semdp.2015.02.013. Epub 2015 Feb 4.
9
Cell-Free Human Papillomavirus-DNA for Monitoring Treatment Response of Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
Laryngoscope. 2022 Mar;132(3):560-568. doi: 10.1002/lary.29739. Epub 2021 Jul 8.
10
Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma.
Oral Oncol. 2023 May;140:106361. doi: 10.1016/j.oraloncology.2023.106361. Epub 2023 Mar 23.
引用本文的文献
1
Targeted Screening Strategies for Head and Neck Cancer: A Global Review of Evidence, Technologies, and Cost-Effectiveness.
Diagnostics (Basel). 2025 Aug 20;15(16):2095. doi: 10.3390/diagnostics15162095.
2
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.
Ger Med Sci. 2025 Jun 24;23:Doc03. doi: 10.3205/000339. eCollection 2025.
3
[Epidemiology and prevention of oropharyngeal cancer : Summary of the new German S3 guideline].
HNO. 2025 Mar;73(3):213-224. doi: 10.1007/s00106-025-01552-0.
4
Diagnostic Accuracy of Circulating Tumor HPV DNA Testing in Patients With a Lateral Neck Mass.
JAMA Otolaryngol Head Neck Surg. 2024 Sep 19;150(12):1089-96. doi: 10.1001/jamaoto.2024.2702.
5
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods.
Microorganisms. 2024 Jul 19;12(7):1482. doi: 10.3390/microorganisms12071482.
6
Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis.
BMC Infect Dis. 2024 May 23;24(1):516. doi: 10.1186/s12879-024-09357-2.
7
De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy.
Viruses. 2024 Mar 29;16(4):536. doi: 10.3390/v16040536.
8
Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
JAMA Otolaryngol Head Neck Surg. 2024 May 1;150(5):444-450. doi: 10.1001/jamaoto.2024.0350.
9
Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma.
Am J Clin Pathol. 2024 Jun 3;161(6):570-578. doi: 10.1093/ajcp/aqad185.
10
Comparing the Diagnostic Performance of Quantitative PCR, Digital Droplet PCR, and Next-Generation Sequencing Liquid Biopsies for Human Papillomavirus-Associated Cancers.
J Mol Diagn. 2024 Mar;26(3):179-190. doi: 10.1016/j.jmoldx.2023.11.007. Epub 2023 Dec 15.
本文引用的文献
1
A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization.
Clin Cancer Res. 2021 Oct 1;27(19):5307-5316. doi: 10.1158/1078-0432.CCR-21-0293.
2
Human Papillomavirus in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Cancers (Basel). 2020 Dec 25;13(1):45. doi: 10.3390/cancers13010045.
3
Cell-Free HPV-DNA as a Biomarker for Oropharyngeal Squamous Cell Carcinoma-A Step Towards Personalized Medicine?
Cancers (Basel). 2020 Oct 15;12(10):2997. doi: 10.3390/cancers12102997.
4
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
J Clin Oncol. 2020 Apr 1;38(10):1050-1058. doi: 10.1200/JCO.19.02444. Epub 2020 Feb 4.
5
Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Cancer Cytopathol. 2019 Oct;127(10):632-642. doi: 10.1002/cncy.22178. Epub 2019 Sep 11.
6
HPV testing through p16 immunocytochemistry in neck-mass FNA and its correlation with tissue samples.
Cancer Cytopathol. 2019 Jul;127(7):458-464. doi: 10.1002/cncy.22156. Epub 2019 Jun 27.
7
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
Clin Cancer Res. 2019 Aug 1;25(15):4682-4690. doi: 10.1158/1078-0432.CCR-19-0211. Epub 2019 May 14.
8
Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals.
J Clin Oncol. 2019 Jun 20;37(18):1538-1546. doi: 10.1200/JCO.19.00370. Epub 2019 Apr 26.
9
Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
Cytopathology. 2018 Oct;29(5):449-454. doi: 10.1111/cyt.12581. Epub 2018 Jul 23.
10
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5115-E5124. doi: 10.1073/pnas.1804184115. Epub 2018 May 14.
Zotero 插件